文献速递免疫规划慢病防控与筛查

类风湿关节炎患者蜱传脑炎病毒疫苗接种的免疫原性及年龄对体液和细胞免疫应答的影响

Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis.
PubMed 文献 · Vaccine · 2024-01-18

这项对照横断面队列研究纳入36例类风湿关节炎患者和112名健康对照,评估蜱传脑炎病毒疫苗接种后的抗体和细胞应答。类风湿关节炎患者的抗蜱传脑炎病毒IgG低于健康对照,且受接种时年龄、距末次接种时间和病程影响;细胞免疫和亲和力高应答者在类风湿关节炎中较少见;接受加强接种的类风湿关节炎患者更可能显示较高的抗蜱传脑炎病毒IgG应答。

要点

  • 类风湿关节炎患者的抗蜱传脑炎病毒IgG低于健康对照。
  • 细胞免疫和亲和力高应答者在类风湿关节炎中较少见。
  • 接受加强接种的类风湿关节炎患者更可能显示较高的抗蜱传脑炎病毒IgG应答。

核心结论

  • 类风湿关节炎患者中年龄对抗蜱传脑炎病毒IgG呈负面影响,并提示及时加强接种具有免疫学益处。

研究设计与样本

  • 对照横断面队列研究,纳入36例类风湿关节炎患者和112名健康对照,评估蜱传脑炎病毒疫苗接种后的抗体和细胞应答。

主要发现

  • 类风湿关节炎患者的抗蜱传脑炎病毒IgG低于健康对照,且受接种时年龄、距末次接种时间和病程影响。
  • 细胞免疫和亲和力高应答者在类风湿关节炎中较健康对照少见。
  • 接受加强接种的类风湿关节炎患者比未接受者更可能显示较高的抗蜱传脑炎病毒IgG应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inactivated vaccines, such as tick-borne-encephalitis-virus-(TBEV) vaccine, have been discussed as less immunogenic in elderly and in immunocompromised patients. In this controlled cross-sectional cohort study, the antibody and cellular responses after TBEV-vaccination were investigated in 36 rheumatoid arthritis (RA) patients and 112 healthy controls (HC) by evaluating IgG-anti-TBEV concentration, neutralization and relative avidity index (RAI). Cellular reactivity was assessed by IFNgamma-producing spot-forming-units (SFU) by ELISPOT assay and flow cytometry. RA patients showed lower IgG-anti-TBEV compared to HC, which were influenced by age at and time since last TBEV vaccination and disease duration. High-responders regarding cellular immunity and avidity were less frequent in RA compared to HC. RA patients who had received booster vaccinations were more likely to demonstrate higher IgG-anti-TBEV responses compared to those who had not. In conclusion, RA patients showed a negative effect of age on anti-TBEV-IgG and immunological benefits of timely booster vaccination are suggested.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rack C, Almanzar G, Schäfer A, et al. Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis. Vaccine. 2024. PMID: 38242736. doi:10.1016/j.vaccine.2024.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。